Self monitoring warfarin safe and effective

In this meta-analysis of randomized trials of home versus center-based INR monitoring, patients with home monitors had a 50% reduction in thromboembolic events, with no difference in major bleeding or death. Patients on warfarin should be considered for home monitoring at the time of discharge (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment